Study of HDL function in patients with vasospastic angina.
Not Applicable
Recruiting
- Conditions
- Ischemic heart disease
- Registration Number
- JPRN-UMIN000020942
- Lead Sponsor
- Tokorozawa Heart Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients who have residual organic coronary obstructive lesions which need revascularization 2) End-stage renal disease (eGFR<30 ml/min) except for patients under hemodialysis 3) Subjects who are pregnant or hope to be pregnant 4) Shock 5) Subjects whose doctor in charge do not agree to join the trial
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method HDL function (the ability of cholesterol efflux, antioxidant effects, anti-inflammatory effects, endothelial function)
- Secondary Outcome Measures
Name Time Method Blood analyses including Hemoglobin A1c levels, Lipid profile, renal function, hepatic function, etc.